Table 2.
Inhibitor of autophagy | Type of SCI model | Mechanisms and outcomes | Reference |
---|---|---|---|
VPA | Chronic traumatic SCI in rats | Decrease in autophagic cell death in ventral horn motoneurons and prevention of myelin sheath damage promoted recovery of motor function. | Hao et al., 2013 |
E2 | Acute and subacute traumatic SCI in rats | Inhibition of excessive autophagy (decreases in expression of Beclin-1 and LC3B II) decreased loss of motoneurons leading to neuroprotective effects of E2 and improvement of locomotor function. | Lin et al., 2016 |
3-MA | Acute hemisection SCI in rats | Inhibitor of autophagy (blockage of formation of autophagosomes via inhibition of PI3K) significantly promoted survival of rubrospinal neurons at remote regions and improved spontaneous functional recovery. | Bisicchia et al., 2017 |
Ginsenoside Rb1 | Acute and subacute traumatic SCI in rats | Inhibition of autophagy (decreases in expression of Beclin-1 and LC3B II) reduced loss of motoneurons and promoted functional recovery. | Wang et al., 2018 |
3-MA: 3-Methyladenine; E2: 17β-Estradiol; LC3B II: microtubule-associated protein 1 light chain 3B; PI3K: class III phosphatidylinositol 3-kinase; SCI: spinal cord injury; VPA: valproic acid.